IRCT138710291562N1已完成2 期
Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •Hemodialysis patients > 18 yo suffering from pruritus for at least 6 weeks, and who have not responded to other drugs
- •Willing and able to give informed concent
排除标准
- •Known dermatologic, liver, metabolic disease, or any other disease or condition other than ESRD that causes pruritus
- •consumption of antihistamines or other antipruritic drugs
- •Lactase deficiency
研究者
相似试验
已完成
不适用
A comparative study of cromolyn sodium gel 4% and pimecrolimus cream 1% anti pruritis effects on end stage renal failure patients undergoing dialysis in Ahwaz Imam Khomeini hospital in 2011End stage renal disease.End stage renal diseaseN 18.0IRCT201107095069N3Gachsaran Islamic Azad University60
已完成
不适用
Assessment of the effects of topical sodium cromoglicate on itch and flare in human skinISRCTN35671014Hewlett Healthcare Ltd (UK)60
进行中（未招募）
不适用
EFFICACY OF ORAL SODIUM CROMOGLICATE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A MULTI-CENTRE, RANDOMIZED, GROUP COMPARATIVE, DOUBLE -BLIND, PLACEBO CONTROLLED STUDYIRRITABLE BOWEL SYNDROMEEUCTR2005-003625-46-PLItalchimici S.p.A.180
进行中（未招募）
不适用
EFFICACY OF ORAL SODIUM CROMOGLICATE IN PATIENTS WITH IRRITABLE BOWELSYNDROME: A MULTI-CENTRE, RANDOMIZED, GROUP COMPARATIVE, DOUBLE -BLIND,PLACEBO CONTROLLED STUDYIRRITABLE BOWEL SYNDROMEMedDRA version: 12.0Level: LLTClassification code 10023003Term: Irritable bowel syndromeEUCTR2005-003625-46-SKItalchimici S.p.A.180
进行中（未招募）
1 期
EFFICACY OF ORAL SODIUM CROMOGLICATE IN PATIENTS WITH IRRITABLE BOWELSYNDROME: A MULTI-CENTRE, RANDOMIZED, GROUP COMPARATIVE, DOUBLE -BLIND,PLACEBO CONTROLLED STUDYIRRITABLE BOWEL SYNDROMEMedDRA version: 12.0Level: LLTClassification code 10023003Term: Irritable bowel syndromeEUCTR2005-003625-46-CZItalchimici S.p.A.180